Curasan.de - Curasan Ag Company News Section

Curasan Ag Information
  • Andrea Weidner
  • curasan AG Lindigstra├če 4 63801 Kleinostheim Germany
  • Phone: 49 (0)6027 40 900-51
  • URL: http://www.curasan.de
  • curasan AG is publicly traded (ISIN: DE 000 549 453 8) and is one of the leading firms in the field of bone and tissue regeneration. In addition to the synthetic Cerasorb┬« bone regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to bring further medical products to market readiness and to market them via well-positioned contractual partners in various submarkets.
Curasan Ag Press Release -

Curasan.de

  • curasan AG receives license for Osbone(R) Dental in the USA
  • curasan AG, which is listed in the General Standard of the German Stock Exchange has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone« Dental which already has been authorized in the EU as Osbone«.
  • February 11, 2011
  • curasan AG signs sales agreement with Stryker S.A
  • curasan AG, listed in the General Standard of the German Stock Exchange has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications.
  • February 10, 2011
  • Curasan Inc. And TransCorp Spine Inc. Sign Supply Agreement For The US-Market
  • curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb« Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine.
  • January 12, 2011
  • curasan AG scouts for sales partners for ATR(R)
  • Supporting wound healing and tissue regeneration through the extraction of autologous platelet-mediator-concentrate (PMC) - high patient compatibility using autologous blood - No need for centrifuges and external laboratories
  • July 28, 2010